News from the FDA/CDC

FDA panel backs new COVID booster focusing only on variants


 

Informing the public

Dr. Marks also stressed the need to better convey the benefits of vaccination to people in the United States.

CDC data estimate that 70% of the U.S. population completed an initial series of the original monovalent vaccines, with only 17% then getting bivalent shots. There’s even a decline among people ages 65 and older. CDC estimates 94% of this group completed their primary series, but only 43% got the bivalent booster dose.

“We have to do better because we have not done a good job today communicating to the American public what’s going on here,” Marks said.

Researchers also are still trying to determine the best timing for people to get additional COVID shots. Finding the “sweet spot” where people can maximize additional protection is tricky, with people most protected if they happen to get shot near the beginning of an uptick in viral spread, the CDC’s Ruth Link-Gelles, PhD, MPH, told the panel during a presentation.

“You’re going to get the best incremental benefit if it’s been longer since your last vaccine,” she said. “But of course, if you wait too long since your last vaccine, you’re left with very little protection, and so you’re at higher risk of severe illness.”

Like Dr. Marks, Dr. Link-Gelles stressed the need for persuading more people to get follow-on vaccines.

“Most Americans, at this point, haven’t even received the bivalent and so are a year or more out from their monovalent dose and so have relatively little protection left,” she said.

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Review supports continued mask-wearing in health care visits
Journal of Clinical Outcomes Management
COVID boosters effective, but not for long
Journal of Clinical Outcomes Management
Study finds COVID-19 boosters don’t increase miscarriage risk
Journal of Clinical Outcomes Management
One in 10 people who had Omicron got long COVID: Study
Journal of Clinical Outcomes Management
COVID nonvaccination linked with avoidable hospitalizations
Journal of Clinical Outcomes Management
We may need a new defense against new COVID variants
Journal of Clinical Outcomes Management
COVID vaccines safe for young children, study finds
Journal of Clinical Outcomes Management
Sewer data says Ohio person has had COVID for 2 years
Journal of Clinical Outcomes Management
Millions who had COVID-19 still don’t have sense of smell, taste
Journal of Clinical Outcomes Management
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
Journal of Clinical Outcomes Management